I remember the call from our head of surgery like it was yesterday. "The Mepilex order didn't ship. We have nothing for the Smith, Jones, and Baker procedures tomorrow." My stomach dropped. I'd taken a chance on a cheaper supplier to save the hospital about $200. That decision, based purely on price, ended up costing us nearly $12,000 in expedited shipping, agency nurse overtime, and a lot of lost goodwill with a grumpy surgeon. It was a brutal lesson in the difference between price and cost.
Most people in my role—procurement and admin for healthcare facilities—think the main job is to get the lowest price. They ask the question, "What's your best per-unit cost?" But that's the wrong question. The real question is, "What's the total cost of getting this wrong?"
The Surface Problem: I Need to Cut Costs
Let's be honest. The pressure from finance is real. Every quarter, I get an email asking for a 5% reduction in our medical supplies spend. My boss, who reports to the CFO, wants to see savings on paper. So, naturally, when a new supplier offers a box of surgical gloves for 15% less than our current Molnlycke contract, my ears perk up.
I started my purchasing career in 2020, managing supplies for a 400-bed hospital. Back then, I made the mistake of chasing every discount. I switched brands for everything—from incontinence pads to surgical drapes—based on nothing more than a lower invoice total.
The Deeper Reason: The Cost Isn't on the Invoice
Here's the thing nobody in a procurement seminar tells you: the cheapest product is almost never the cheapest solution. Most buyers focus on per-unit pricing and completely miss the three huge cost drivers that come after the purchase: failure, time, and trust.
Failure Costs: A cheaper surgical drape that tears during a procedure? You're not just replacing a drape—you're risking a surgical site infection. A generic wound dressing that doesn't manage exudate as well as Mepilex? That's more nurse visits, more dressing changes, and a slower healing time. I saw this firsthand in our 2024 vendor consolidation project. We trialed a budget foam dressing. On paper, it saved 20%. In reality, our clinicians reported 40% more changes needed, negating any savings.
Time Costs: Every time a clinician needs to troubleshoot a product that doesn't work perfectly, that's time away from a patient. Processing 60 to 80 orders for different product lines from multiple vendors eats my team's month. When I consolidated our orders, moving more products under the Molnlycke brand, I cut our ordering time from about 8 hours a month down to 3. That's a tangible saving the finance guys don't see.
Trust Costs: The vendor who couldn't provide proper invoicing cost my last department $2,400 in rejected expenses. More critically, if a product fails and you have no relationship with the supplier, you're in a crisis alone. Molnlycke's reputation and their Safetac technology in the wound care line aren't just marketing—they're a promise of consistency. When you have a problem, you have a partner with a proven track record, not just a faceless supplier.
The Price of Getting It Wrong
Calculating the worst-case scenario when you choose an unfamiliar, cheaper supplier is terrifying. The upside of switching? A potential $2,000 quarterly saving. The risk? Missing a critical delivery for a scheduled surgery. I'd be looking at the cost of wasting an entire OR team's time, potentially losing a patient's slot, and having to explain to the COO why we wasted $15,000 in operating expenses to save $2,000. Is $2,000 worth potentially losing a patient's trust or a surgeon's goodwill? I'd say no, emphatically no.
One of my biggest regrets: not having a clear process for evaluating total system cost earlier in my career. The consequences of a bad vendor choice—a sole-supplier that can't deliver—are consequences I'm still dealing with years later. I now have a hard rule: before switching for price, I require a 3-month trial in a controlled setting to collect real-world failure data. That has saved me more than once.
When I took over purchasing during the 2020 pandemic, the chaos was immense. Buyers were desperate for any supply. We spent a small fortune on unreliable vendors. The time I spent arguing with suppliers about shipping delays and damaged goods was time I should have been supporting our clinical teams.
A Smarter Way Forward: Certainty Over Price
So, what have I learned? It comes down to the value of certainty. In a hospital, certainty is oxygen. You need to know your surgical gloves will be there. You need to know your wound care products perform exactly as the studies say they will.
Molynlycke isn't the absolute cheapest supplier on the market. I know that. But they are one of the most reliable partners for delivering certainty. Their Safetac technology on Mepilex, for example, is a proven asset that reduces pain and protects periwound skin, directly correlating to better patient outcomes and faster discharge times—which saves the hospital real money.
After getting burned twice by 'probably on time' promises from bargain-bin suppliers, I now budget for the trusted brand. For my current health system, the total cost of ownership for wound care and surgical products includes:
- The base product price
- The clinical effectiveness and avoidance of complications
- The operational efficiency of a single, reliable logistics chain
- The vendor's ability to support us in a crisis
You can look for a price comparison for surgical drapes online (standard drapes from a budget online printer might be $80, but the cost if it tears in surgery is exponentially more). The market rate for a box of specialized gloves fluctuates, but the value of a glove that doesn't tear at a critical moment is priceless.
In March 2024, we paid a premium to stick with our Molnlycke contract for a rush order of Melgisorb. The alternative was a cheaper product that might not have absorbed correctly. We spent $300 more. The alternative was having to explain to a surgeon why their patient's wound was leaking. The cost of that conversation? Incalculable.
